Login to Your Account



Breo drops TORCH, fails to extend lives in massive SUMMIT trial

By Jennifer Boggs
Managing Editor

Wednesday, September 9, 2015
Data from the much-anticipated SUMMIT study failed to show that Relvar/Breo Ellipta statistically significantly extended the lives of COPD patients.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription